Cellular Origins of EGFR‐Driven Lung Cancer Cells Determine Sensitivity to Therapy

Cellular Origins of EGFR‐Driven Lung Cancer Cells Determine Sensitivity to Therapy

Abstract Targeting the epidermal growth factor receptor (EGFR) with tyrosine kinase inhibitors (TKIs) is one of the major precision medicine treatment options for lung adenocarcinoma. Due to common development of drug resistance to first‐ and second‐generation TKIs, third‐generation inhibitors, incl...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Fan Chen, Jinpeng Liu, Robert M. Flight, Kassandra J. Naughton, Alexsandr Lukyanchuk, Abigail R. Edgin, Xiulong Song, Haikuo Zhang, Kwok‐Kin Wong, Hunter N. B. Moseley, Chi Wang, Christine F. Brainson
Formato: article
Lenguaje:EN
Publicado: Wiley 2021
Materias:
alveolar
bronchiolar
EGFR
lung cancer
organoids
Science
Q
Acceso en línea:https://doaj.org/article/1d70799b294842b6a8cf3f7bd6a3471b
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/1d70799b294842b6a8cf3f7bd6a3471b

Ejemplares similares